d bp227 δ bpeab oprb amrab opra (ATCC)

ATCC is a verified supplier

ATCC manufactures this product

About

News

Press Release

Team

Advisors

Partners

Contact

Bioz Stars

Bioz vStars

Buy from Supplier

Structured Review

ATCC d bp227 δ bpeab oprb amrab opra
In vitro susceptibility of isogenic B. pseudomallei strains expressing or lacking defined efflux pumps

D Bp227 δ Bpeab Oprb Amrab Opra, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/wright/Ophiostoma+europhioides+(Wright+et+Cain)+Solheim%2C+teleomorph/pmc05890739-39-82-159
Average 90 stars, based on 4 article reviews

d bp227 δ bpeab oprb amrab opra - by Bioz Stars, 2026-11

90/100 stars

Images

1) Product Images from "Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance"

Article Title: Finafloxacin overcomes Burkholderia pseudomallei efflux-mediated fluoroquinolone resistance

Journal: Journal of Antimicrobial Chemotherapy

doi: 10.1093/jac/dkw529

Figure Legend Snippet: In vitro susceptibility of isogenic B. pseudomallei strains expressing or lacking defined efflux pumps

Techniques Used: In Vitro, Expressing

Plasmid Preparation:

Article Title: Report of the DNA committee and catalogues of cloned and mapped genes, markers formatted for PCR and DNA polymorphisms (Part 10 of 27)
Article Snippet: llq23-qler APOA4 ACT(Thr) 5 inn LI ACT .78 .28 102 362 TCT(Ser) L2 TCT .22 above reported in Undefined; A->T transversion in codon 347 revealed by PCR and ASOs on doc blot APOA1-C3-A4 gene pUC19 Amp/4/ SK Karat Xbal El 23 .23 .29 129 2484,3229, cluster probe 4/5 Hindm lhanasis/1 E2 1.8,21.2 .77 3230,82 B1 10.8.23 .87 .2 129 B2 7 .13 APOA1-C3-A4 gene pUC19 Amp/1.5/ SK Karat Bgin Cl 5.8 .67 .34 132 cluster probe 6/7 Smal thanasis/1 C2 6.4 .33 PstI FI 7 .9 .16 129 3231,3907.. F2 3.6 .1 3229,82 J1 7 .5 .37 129 J2 2.8,4.2 .5 .8 kb fragment detected when both PstI sites (alleles F2 and J2) present APOA4.Clonel pUC19/?/PvuII SK Karat Bgm Cl 5.8 .67 .34 132 3907.3229 thanasis/2 C2 6.4 .33 APOA4.PCR1.1 7/7/7 LI ACT .78 .28 102 362 APOA4.PCR1.2 L2 TCT .22 above reported in Undefined; A->T transversion in codon 347 revealed by PCR and ASOs on dot bloc

Bacteria:

Article Title: Exploring the Antimicrobial and Antioxidant Activities of Streptomyces sp. EIZ2 Isolated from Moroccan Agricultural Soil
Article Snippet: .. Multi-Drug-Resistant Bacteria (MDR) PC BC NC D DM BA EA A RP D Clinical Proteus sp. 19K1313 - - 19.67 ± 1.53 20 ± 1.00 - Clinical Proteus vulgaris 16C1737 25.5 ± 0.71 - 20 ± 1.00 15 ± 1.00 - Clinical Klebsiella pneumonie 19K 929 - - 16 ± 0.58 22.66 ± 1.53 - Clinical Listeria monocytogenes 25 ± 0.71 - - 30 ± 2.08 - Clinical Escherichia coli 19L2418 - - - 15.67 ± 1.15 - Clinical Klebsiella pneumoniae 20B1572 - - - 40.67 ± 0.58 - Candida albicans ATCC 60,193 27 ± 2.83 - - 40.33 ± 0.57 - Values are the means ± SD (n = 2). ..

Article Title: Exploring the Antimicrobial and Antioxidant Activities of Streptomyces sp. EIZ2 Isolated from Moroccan Agricultural Soil
Article Snippet: .. Multi-Drug-Resistant Bacteria (MDR) PC BC NC D DM BA EA A P D Clinical Proteus sp. 19K1313 - - 19.67 ± 1.53 20 ± 1.00 - Clinical Proteus vulgaris 16C1737 25.5 ± 0.71 - 20 ± 1.00 15 ± 1.00 - Clinical Klebsiella pneumonie 19K 929 - - 16 ± 0.58 22.66 ± 1.53 - Clinical Listeria monocytogenes 25 ± 0.71 - - 30 ± 2.08 - Clinical Escherichia coli 19L2418 - - - 15.67 ± 1.15 - Clinical Klebsiella pneumoniae 20B1572 - - - 40.67 ± 0.58 - Candida albicans ATCC 60,193 27 ± 2.83 - - 40.33 ± 0.57 - Values are the means ± SD (n = 2). ..

other:

Article Title: Report of the committee on human gene mapping by recombinant DNA techniques (Part 5 of 6)
Article Snippet: 21ql 1.2-q21 D21S11 pPW236B pBR328/1.85/ PC Watkins/2 EcoRl 0.9 A1 1.9 .75 .30 72 629 EcoRJ A2 2.9 .25 above reported in North Americans A1 .70 .33 108 294 A2 .30 above reported in Greeks pG95-alphal-lla pUC8/1.5/ BN Whitc/1 EcoRl A1 1.95 .68 .34 68 214 Hindlll/ A2 2.95 .32 EcoRJ above reported 4.0 in Caucasians pPW236B pBR328/1.85/ PC Watkins/2 TaqI B1 .69 .34 108 214294, EcoRl B2 5 5 .31 629 pG95-alphal-lla pUC8/1.5/ BN White/1 above reported in Greeks Hindlll/ EcoRl pG95-alphal-llb pUC8/0.45/ BN White/1 Hindi Cl 2.6 .69 .34 68 214 Hindlll/ EcoRl C2 2.3 .31

Article Title: Recombinant host cells comprising phosphoketolases
Article Snippet: MC2 155 169631304 complement(NC_010397.1: 1626 YP_001704953.1 1827 Mycobacterium 4294451 . . . 4296532) abscessus 240168870 NZ_ACBV01000011.1: 1627 ZP_04747529.1 1828 Mycobacterium 33884 . . . 35974 kansasii ATCC 12478 183980733 NC_010612.1: 853987 . . . 856071 1628 YP_001849024.1 1829 Mycobacterium marinum M 15607549 NC_000962.2: 491786 . . . 493858 1629 NP_214922.1 1830 Mycobacterium tuberculosis H37Rv 41409983 NC_002944.2: 4345845 . . . 4347932 1630 NP_962819.1 1831 Mycobacterium avium subsp. paratuberculosis K-10 254818871 complement(NZ_ABIN01000026.1: 1631 ZP_05223872.1 1832 Mycobacterium 2280 . . . 4439) intracellulare ATCC 13950 226304961 NC_012490.1: 1605870 . . . 1607948 1632 YP_002764919.1 1833 Rhodococcus erythropolis PR4 111019190 complement(NC_008268.1: 1633 YP_702162.1 1834 Rhodococcus 2308925 . . . 2311045) jostii RHA1 54027320 complement(NC_006361.1: 1634 YP_121562.1 1835 Nocardia 5652808 . . . 5654895) farcinica IFM 10152 227978095 NZ_ABVA01000001.1: 1635 ZP_04025361.1 1836 Tsukamurella 785441 . . . 787570 paurometabola DSM 20162 262204223 complement(NC_013441.1: 1636 YP_003275431.1 1837 Gordonia 4704088 . . . 4706208) bronchialis DSM 43247 256831883 complement(NC_013174.1: 1637 YP_003160610.1 1838 Jonesia 683848 . . . 685947) denitrificans DSM 20603 260517199 complement(NZ_ABUN01000002.1: 1638 ZP_05816650.1 1839 Sanguibacter 90744 . . . 92939) keddieii DSM 10542 229243856 complement(NZ_ABTJ01000131.1: 1639 ZP_04368027.1 1840 Cellulomonas 4381 . . . 6468) flavigena DSM 20109 229821528 NC_012669.1: 3401218 . . . 3403323 1640 YP_002883054.1 1841 Beutenbergia cavernae DSM 12333 227428424 complement(NZ_ABVC01000008.1: 1641 ZP_03911481.1 1842 Xylanimonas 150308 . . . 152407) cellulosilytica DSM 15894 119717178 complement(NC_008699.1: 1642 YP_924143.1 1843 Nocardioides 3139954 . . . 3142044) sp. JS614 227381337 complement(NZ_ABUC01000011.1: 1643 ZP_03864789.1 1844 Kribbella 233655 . . . 235784) flavida DSM 17836 88856399 NZ_AAOB01000010.1: 1644 ZP_01131057.1 1845 marine 2970 . . . 5138 actinobacterium PHSC20C1 170780609 NC_010407.1: 179995 . . . 182112 1645 YP_001708941.1 1846 Clavibacter michiganensis subsp. Sepedonicus 50954174 NC_006087.1: 335128 . . . 337257 1646 YP_061462.1 1847 Leifsonia xyli subsp. xyli str.

In Vitro:

Article Title: Madurella mycetomatis Is Not Susceptible to the Echinocandin Class of Antifungal Agents
Article Snippet: .. Since the isolates of Odabasi et al. were not used in our study, we cannot exclude this possibility. table ft1 table-wrap mode="anchored" t5 caption a7 Species Strain MIC (MEC) (mg/liter) a KTZ CAS ANI MICA M. Mm31 0.063 64 >128 >128 mycetomatis Mm35 1 128 >128 >128 Mm36 0.063 128 >128 >128 Mm39 0.031 64 >128 >128 Mm41 0.125 16 0.5 8 Mm43 0.063 128 >128 128 Mm45 0.25 64 >128 >128 Mm46 <0.016 64 >128 >128 Mm49 0.031 32 >128 >128 Mm50 0.063 128 >128 >128 Mm52 0.25 >128 >128 >128 Mm54 0.031 64 >128 >128 Mm55 0.25 128 >128 >128 Mm64 0.063 64 >128 >128 Mm68 0.125 64 >128 >128 Mm73 0.063 64 >128 >128 Mm83 0.125 128 >128 128 A. fumigatus ATCC 204305 ND 128 (0.125) >128 (<0.007) >128 (<0.007) Open in a separate window a The in vitro antifungal susceptibilities of M. mycetomatis and A. fumigatus to ketoconazole (KTZ), caspofungin (CAS), anidulafungin (ANI), and micafungin (MICA) are shown. .. table ft1 table-wrap mode="anchored" t5 caption a7 Species Strain MIC (MEC) (mg/liter) a KTZ CAS ANI MICA M. Mm31 0.063 64 >128 >128 mycetomatis Mm35 1 128 >128 >128 Mm36 0.063 128 >128 >128 Mm39 0.031 64 >128 >128 Mm41 0.125 16 0.5 8 Mm43 0.063 128 >128 128 Mm45 0.25 64 >128 >128 Mm46 <0.016 64 >128 >128 Mm49 0.031 32 >128 >128 Mm50 0.063 128 >128 >128 Mm52 0.25 >128 >128 >128 Mm54 0.031 64 >128 >128 Mm55 0.25 128 >128 >128 Mm64 0.063 64 >128 >128 Mm68 0.125 64 >128 >128 Mm73 0.063 64 >128 >128 Mm83 0.125 128 >128 128 A. fumigatus ATCC 204305 ND 128 (0.125) >128 (<0.007) >128 (<0.007) Open in a separate window a The in vitro antifungal susceptibilities of M. mycetomatis and A. fumigatus to ketoconazole (KTZ), caspofungin (CAS), anidulafungin (ANI), and micafungin (MICA) are shown.

Review